2m 2m 2m 2m 2m 2m 2m
ADICET BIO (ACET)
NASDAQ
$7.70-$0.13 (-1.66%)
Price as of Jun 03, 2026 7:58 PM EDT- $87.0MMarket Cap
- -38.13%1-Year Change
- BiotechnologyIndustry
ADICET BIO (ACET)
$7.70-$0.13 (-1.66%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.8M -46.08% | 10.7M N/A | N/A N/A | 25.0M +156.83% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 5.8M -46.08% | 10.7M N/A | 0 -100.00% | 25.0M +156.83% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -99.1M -0.20% | -99.3M -6.34% | -106.0M +48.84% | -71.2M +45.57% | |
Depreciation and Amortization Expense | 6.4M -1.35% | 6.5M +6.07% | 6.1M +136.82% | 2.6M +67.43% | |
Total Operating Expenses | 122.1M -4.31% | 127.6M -16.06% | 152.0M +55.87% | 97.5M +37.07% | |
Operating Profit | -122.1M -4.31% | -127.6M -16.06% | -152.0M +109.56% | -72.6M +18.10% | |
Interest Income | 5.8M -46.08% | 10.7M +7.38% | 10.0M +165.37% | 3.8M +4,031.87% | |
Interest Expense | -36,000 +800.00% | -4,000 -84.00% | -25,000 -68.75% | -80,000 -54.55% | |
Interest Income and Expense and Net | 5.7M -46.40% | 10.7M +7.61% | 10.0M +170.46% | 3.7M +4,429.41% | |
Total Nonoperating Income and Expense | -430,000 +98.16% | -217,000 -62.13% | -573,000 -37.65% | -919,000 +51.65% | |
Income before Taxes | -116.8M -0.27% | -117.1M -17.90% | -142.7M +104.41% | -69.8M +12.34% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -116.8M -0.27% | -117.1M -17.90% | -142.7M +104.41% | -69.8M +12.57% | |
Net Income from Continuing Operations Applicable to Common | -116.8M -0.27% | -117.1M -17.90% | -142.7M +104.41% | -69.8M +12.34% | |
Basic EPS and Net Income | -16.95 +1,174.44% | -1.33 -59.82% | -3.31 +94.71% | -1.70 -15.00% | |
Diluted EPS and Net Income | -16.95 +1,174.44% | -1.33 -59.82% | -3.31 +94.71% | -1.70 -15.00% | |
Basic Weighted Average Shares | 6.9M -92.16% | 87.9M +104.14% | 43.0M +4.78% | 41.1M +32.72% | |
Diluted Weighted Average Shares | 6.9M -92.16% | 87.9M +104.14% | 43.0M +4.78% | 41.1M +32.72% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 38.9M -31.11% | 56.5M -64.63% | 159.7M -38.01% | 257.7M -7.17% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 38.9M -31.11% | 56.5M -64.63% | 159.7M -38.01% | 257.7M -7.17% | |
Total Current Assets | 160.9M -10.66% | 180.1M +11.01% | 162.3M -37.84% | 261.0M -7.58% | |
Accumulated Depreciation | 27.4M +28.49% | 21.3M +43.56% | 14.8M +69.62% | 8.8M +38.37% | |
Property and Plant and Equipment and Net | 16.5M -26.60% | 22.5M -15.88% | 26.8M -6.73% | 28.7M +96.07% | |
Total Long-Term Assets | 76,000 -82.24% | 428,000 -47.93% | 822,000 -32.12% | 1.2M -35.82% | |
Total Assets | 192.4M -12.65% | 220.2M +6.23% | 207.3M -37.31% | 330.7M -2.43% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 21.5M +11.03% | 19.4M +0.54% | 19.3M -2.13% | 19.7M +20.78% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 62,000 -46.55% | 116,000 -10.77% | 130,000 +14.04% | 114,000 -99.41% | |
Total Liabilities | 33.1M -1.38% | 33.6M -9.46% | 37.1M -3.21% | 38.4M +7.10% | |
Retained Earnings | -614.7M +23.46% | -497.9M +30.76% | -380.8M +59.91% | -238.1M +41.46% | |
Total Stockholders Equity | 159.2M -14.68% | 186.6M +9.66% | 170.2M -41.79% | 292.3M -3.56% | |
Total Shares Outstanding | 9.6M -88.39% | 82.6M +90.82% | 43.3M +8.89% | 39.7M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -95.2M +3.10% | -92.4M -1.43% | -93.7M +109.35% | -44.8M -12.31% | |
Capital Expenditures | 1.7M +55.46% | 1.1M -74.96% | 4.5M -73.40% | 16.8M +28.64% | |
Cash from Investing Activities | 2.4M +102.01% | -119.2M +2,571.19% | -4.5M -73.40% | -16.8M +500.21% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 75.2M -32.40% | 111.3M +47,063.98% | 236,000 -99.43% | 41.5M -82.90% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -2,113.80% +77.47% | -1,191.11% N/A | N/A N/A | -290.32% -54.02% | |
Return on Assets | -56.62% +3.34% | -54.79% +3.31% | -53.03% +154.43% | -20.84% -17.16% | |
Return on Equity | -67.55% +2.89% | -65.65% +6.43% | -61.69% +163.17% | -23.44% -21.94% | |
Revenue Growth | -46.08% N/A | N/A N/A | N/A N/A | 156.83% +443.55% | |
Current Ratio | 7.47 -19.54% | 9.29 +10.41% | 8.41 -36.48% | 13.25 -23.48% | |
Cash Ratio | 1.81 -37.96% | 2.91 -64.82% | 8.28 -36.66% | 13.07 -23.14% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow